Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RBD4059 / Suzhou Ribo
NCT06717074: A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants with Stable Coronary Artery Disease	Recruiting	2	30	Europe	RBD4059, Placebo	Ribocure Pharmaceuticals AB	Stable Coronary Artery Disease CAD	12/25	12/25
NCT05653037: A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects	Active, not recruiting	1	32	RoW	RBD4059, Placebo	Suzhou Ribo Life Science Co. Ltd.	Healthy Volunteers	12/25	12/25